Chronic kidney disease and the global NCDs agenda
暂无分享,去创建一个
Vlado Perkovic | David W. Johnson | S. Chadban | V. Perkovic | B. Neuen | A. Demaio | Brendon Lange Neuen | Steven James Chadban | Alessandro Rhyl Demaio | David Wayne Johnson
[1] David W. Johnson,et al. Global Kidney Health Atlas (GKHA): design and methods. , 2017, Kidney international supplements.
[2] Ashutosh Kumar Singh,et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, Lancet.
[3] Amit X Garg,et al. Worldwide access to treatment for end-stage kidney disease: a systematic review , 2015, The Lancet.
[4] Syed Saad,et al. Assessment of Global Kidney Health Care Status , 2017, JAMA.
[5] S. Agarwal,et al. How to advocate for the inclusion of chronic kidney disease in a national noncommunicable chronic disease program. , 2014, Kidney international.
[6] P. Schauer,et al. Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[7] Dan J Stein,et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, BDJ.
[8] Ashutosh Kumar Singh,et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, The Lancet.
[9] M. Woodward,et al. Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England , 2017, PloS one.
[10] M Arantxa Colchero,et al. Beverage purchases from stores in Mexico under the excise tax on sugar sweetened beverages: observational study , 2016, British Medical Journal.
[11] Bernadette A. Thomas,et al. Global Cardiovascular and Renal Outcomes of Reduced GFR. , 2017, Journal of the American Society of Nephrology : JASN.
[12] V. Mohan,et al. Prevalence of chronic kidney disease and risk factors for its progression: A cross-sectional comparison of Indians living in Indian versus U.S. cities , 2017, PloS one.
[13] V. Jha,et al. Chronic kidney disease: global dimension and perspectives , 2013, The Lancet.